Table 1 Demographics and clinical data of age-related macular degeneration patients
Parameters | Values | Responders | Non-responders | P value |
|---|---|---|---|---|
N | 60 | 39 | 21 | Â |
Patient age (years) | 70.8 ± 9.6 | 71.8 ± 8.9 | 68.9 ± 10.7 | 0.256 |
Sex, N (%) | Â | Â | 0.416 | |
 Male | 35 (58.3) | 21 (53.8) | 14 (66.7) |  |
 Female | 25 (41.7) | 18 (46.2) | 7 (33.3) |  |
Type of CNV | Â | Â | 0.009 | |
 Type 1, N (%) | 32 (53.3) | 16 (41.0) | 16 (76.2) |  |
 Type 2, N (%) | 11 (18.3) | 11 (28.2) | 0 (0.0) |  |
 Mixed type 1 and 2, N (%) | 17 (28.3) | 12(30.8) | 5 (23.8) |  |
Baseline BCVA (ETDRS letters) (mean ± SD) | 50.8 ± 21.4 | 50.0 ± 21.4 | 52.3 ± 21.8 | 0.691 |
Duration of symptoms (weeks) (median, IQR) | 5.0 (1.0, 12.0) | 5.0 (1.0, 12.0) | 7.0 (2.0, 12.0) | 0.462 |
Mean number of injections at 6 months | 4.12 ± 1.03 | 4.03 ± 1.05 | 4.28 ± 1.02 | 0.931 |